Hudson Bay Capital Management »

Janux Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6M 124k 45.43

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices Put Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Alphabet Cap Stk Cl C Put Option (GOOG)
Broadcom Call Option (AVGO)
New York Cmnty Bancorp Com New (NYCB)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Put Option (COIN)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics